Crossmark

Drug pricing for hepatitis B and C in Australia and Japan

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.102118

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Suoh, Maito https://orcid.org/0000-0002-7505-9459
Esmaili, Saeed https://orcid.org/0000-0002-2843-7277
Eslam, Mohammed

George, Jacob
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1107178)

National Health and Medical Research Council (APP2001692)

National Health and Medical Research Council (APP1053206)

National Health and Medical Research Council (APP1196492)

National Health and Medical Research Council (APP1108422)

University of Sydney

Cancer Institute NSW
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-09-08
More Information

This article is maintained by: Elsevier

Article Title: Drug pricing for hepatitis B and C in Australia and Japan

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.102118

Content Type: simple-article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.